gms | German Medical Science

29. Wissenschaftlicher Kongress der Deutschen Hochdruckliga

Deutsche Hochdruckliga e. V. DHL ® - Deutsche Hypertonie Gesellschaft Deutsches Kompetenzzentrum Bluthochdruck

23. bis 25.11.2005, Berlin

Frequency of blood pressure self measurement and success of antihypertensive treatment in a telemonitoring study:the Olmetel study

Häufigkeit der Blutdruckselbstmessung und Erfolg der antihypertensiven Therapie in einer Telemonitoring Studie: die Olmetel Studie

Meeting Abstract

  • S. Ewald - Sankyo Pharma GmbH, Clinical Development, München (München, D)
  • J. vor dem Esche - Telemed Project GmbH, Bergisch Gladbach (Bergisch
  • F. Neikes - Universität Bonn, Division of Hypertension and Vascular Medicine (Bonn, D)
  • T. Mengden - Universität Bonn, Division of Hypertension and Vascular Medicine (Bonn, D)

Hypertonie 2005. 29. Wissenschaftlicher Kongress der Deutschen Hochdruckliga. Berlin, 23.-25.11.2005. Düsseldorf, Köln: German Medical Science; 2006. Doc05hochP27

The electronic version of this article is the complete one and can be found online at:

Published: August 8, 2006

© 2006 Ewald et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.



Objective: We have recently shown that BP self-measurement (BPSM) supervised by telemonitoring gave a detailed impression of BP-development under Olmesartan treatment in a real life condition. The aim of the study was to investigate the relationship between the frequency of measuring (as an indicator of patients compliance) and response to antihypertensive treatment.

Methods: Patients (n= 53) suffering from essential hypertension were treated with Olmesartan. BPSM was conducted throughout a 9-week period using a TensioPhone TP2 device; BP values were stored and auto-matically downloaded to a remote service centre via standard telephone lines. The patients were instructed to measure their BP twice per day. The patients were classified according to the percentage of days they per-formed at least 2 or 1 measurements per day respectively.

Results: The relationship between frequency of systolic (syst.) and diastolic (diast.) BP-recordings (rec.) and BP-reduction is shown in the graph (Figure 1 [Fig. 1]).

Patients who measured their BP more regularly (greater than 2x per day or even greater than 1x per day) showed a greater reduc-tion of BP under antihypertensive treatment.

Conclusions: In the Olmetel Study the patients which followed the instruction to measure their blood pres-sure 2 times per day showed a higher response to antihypertensive treatment with Olmesartan. Whether self-measurement per se resulted in a better compliance or whether the number of recordings was an indicator of good compliance remains to be determined.